Lasa Supergenerics
Lasa Supergenerics Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Lasa Supergenerics
Start SIPLasa Supergenerics Investment Rating
-
Master Rating:
-
Lasa Supergenerics has an operating revenue of Rs. 145.46 Cr. on a trailing 12-month basis. An annual revenue de-growth of -32% needs improvement, Pre-tax margin of -5% needs improvement, ROE of -3% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 29 which is a POOR score indicating inconsistency in earnings, a RS Rating of 4 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 81 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 32 | 34 | 29 | 51 |
| Operating Expenses Qtr Cr | 34 | 34 | 37 | 40 |
| Operating Profit Qtr Cr | -2 | 0 | -8 | 11 |
| Depreciation Qtr Cr | 3 | 3 | 3 | 3 |
| Interest Qtr Cr | 0 | 1 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 1 | -1 |
| Net Profit Qtr Cr | -5 | -7 | -12 | 12 |
Lasa Supergenerics Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 21.43
- 50 Day
- 24.29
- 100 Day
- 27.54
- 200 Day
- 33.15
- 20 Day
- 21.92
- 50 Day
- 24.45
- 100 Day
- 28.28
- 200 Day
- 31.8
Lasa Supergenerics Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 18.61 |
| Second Resistance | 19.11 |
| Third Resistance | 19.86 |
| RSI | 26.28 |
| MFI | 31.02 |
| MACD Single Line | -1.55 |
| MACD | -1.9 |
| Support | |
|---|---|
| First Resistance | 17.36 |
| Second Resistance | 16.61 |
| Third Resistance | 16.11 |
Lasa Supergenerics Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 239,938 | 17,491,480 | 72.9 |
| Week | 185,189 | 13,818,785 | 74.62 |
| 1 Month | 96,993 | 6,797,252 | 70.08 |
| 6 Month | 138,281 | 7,373,122 | 53.32 |
Lasa Supergenerics Result Highlights
Lasa Supergenerics Synopsis
NSE-Medical-Ethical Drugs
Lasa Supergenerics is involved in the business activities of Manufacture of veterinary preparations. Company’s Total Operating Revenue is Rs. 137.13 Cr. and Equity Capital is Rs. 40.67 Cr. for the Year ended 31/03/2022. Lasa Supergenerics Ltd. is a Public Limited Listed company incorporated on 11/11/2016 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24233MH2016PLC274202 and registration number is 274202.| Market Cap | 75 |
| Sales | 145 |
| Shares in Float | 2.28 |
| No of funds | 1 |
| Yield | 1.38 |
| Book Value | 0.5 |
| U/D Vol ratio | 0.8 |
| LTDebt / Equity | |
| Alpha | -0.18 |
| Beta | 1.19 |
Lasa Supergenerics
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 43.78% | 43.78% | 43.78% | |
| Foreign Portfolio Investors | 0.4% | |||
| Individual Investors | 38.13% | 38.01% | 36.74% | |
| Others | 18.09% | 18.21% | 19.08% |
Lasa Supergenerics Management
| Name | Designation |
|---|---|
| Dr. Omkar Pravin Herlekar | Chairman & Managing Director |
| Mr. Shivanand G Hegde | Whole Time Director |
| Mr. Hardesh Raja Tolani | Independent Director |
| Ms. Ekta Avtar Gurnasinghani | Independent Director |
| Mr. Ajay Hareshlal Sukhwani | Independent Director |
| Ms. Manali Roop Bhagtani | Independent Director |
Lasa Supergenerics Forecast
Price Estimates
Lasa Supergenerics FAQs
What is Share Price of Lasa Supergenerics ?
Lasa Supergenerics share price is ₹18 As on 31 March, 2023 | 20:33
What is the Market Cap of Lasa Supergenerics ?
The Market Cap of Lasa Supergenerics is ₹74.4 Cr As on 31 March, 2023 | 20:33
What is the P/E ratio of Lasa Supergenerics ?
The P/E ratio of Lasa Supergenerics is -6.6 As on 31 March, 2023 | 20:33
What is the PB ratio of Lasa Supergenerics ?
The PB ratio of Lasa Supergenerics is 0.5 As on 31 March, 2023 | 20:33